Status:
UNKNOWN
Clinical Characterisation Protocol for COVID-19 in People Living With HIV
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Adult Patients Living With HIV (PLWHIV) With Confirmed Infection With SARS-CoV-2 Since 1st January 2020
Eligibility:
All Genders
18+ years
Brief Summary
There is very little data so far to determine whether people living with HIV (PLWHIV) are at greater risk of COVID-19 acquisition or severe disease. HIV infection is associated with deficiencies in bo...
Detailed Description
Infectious diseases are a major cause of death worldwide. Recently a new coronavirus named SARS-CoV-2 has been identified as responsible of an initial epidemic respiratory disease, named COVID-19, in ...
Eligibility Criteria
Inclusion
- Inclusion criteria for the 250 patients with COVID19
- Patient living with HIV (PLWHIV)
- Patient with confirmed infection with SARS-CoV-2 since 1st January 2020 with and without criteria of hospitalisation.
- Inclusion criteria for the 20 patients without COVID19 (who will only realize the qualitative interview)
- Patient living with HIV (PLWHIV)
- Patient who did not have COVID-19
Exclusion
- Exclusion criteria for the 250 patients with COVID19
- Confirmed diagnosis of another pathogen than SARS-CoV-2
- Refusal by participant, or appropriate representative.
- Being under guardianship or trusteeship mandate for future protection
- Participate to another study without consent of the promoter
- Patients less than 18 years old
- No Beneficiary or entitled to a social security scheme or state medical aid.
- Exclusion criteria for the 20 patients without COVID19 (who will only realize the qualitative interview)
- Refusal by participant, or appropriate representative.
- Being under guardianship or trusteeship mandate for future protection
- Participate to another study without consent of the promoter
- Patients less than 18 years old
- No Beneficiary or entitled to a social security scheme or state medical aid.
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2020
Estimated Enrollment :
270 Patients enrolled
Trial Details
Trial ID
NCT04361604
Start Date
April 1 2020
End Date
October 1 2020
Last Update
April 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Internal Medicine and Clinical Immunology of Professor Cécile Goujard
Le Kremlin-Bicêtre, France